Trials that use: Fisher exact test
New to this method? Read the tutorial →
5,849 results
- S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.: Complete Statistical AnalysisIndependent statistical analysis of S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction: Complete Statistical AnalysisIndependent statistical analysis of S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction: primary endpoint results, effect estimate with confidence…
- S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate…
- S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib: Complete Statistical AnalysisIndependent statistical analysis of S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib: primary endpoint results, effect estimate with…
- S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma: Complete Statistical AnalysisIndependent statistical analysis of S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00003590).
- Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study: Complete Statistical AnalysisIndependent statistical analysis of Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study: primary endpoint…
- SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SAFEIndependent statistical analysis of Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH): primary endpoint results, effect estimate with confidence interval,…
- SAFERIndependent statistical analysis of Sleep Apnea and Fetal Growth Restriction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04084990).
- Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS: Complete Statistical AnalysisIndependent statistical analysis of Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Safety & Immunogenicity of GlaxoSmithKline Biologicals’ Herpes Zoster Vaccine 1437173A: Complete Statistical AnalysisIndependent statistical analysis of Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00920218).
- Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule: Complete Statistical AnalysisIndependent statistical analysis of Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05243862).
- Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B: Complete Statistical AnalysisIndependent statistical analysis of Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Effectiveness of Juvéderm® VOLUMA XC Injectable Gel for Cheek Augmentation: Complete Statistical AnalysisIndependent statistical analysis of Safety and Effectiveness of Juvéderm® VOLUMA XC Injectable Gel for Cheek Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones: Complete Statistical AnalysisIndependent statistical analysis of Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02028559).
- Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts: Complete Statistical AnalysisIndependent statistical analysis of Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy of Abatacept in IgG4-Related Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Abatacept in IgG4-Related Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03669861).
- Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01208337).
- Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma: primary endpoint results, effect estimate with confidence…
- Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction.: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04396795).
- Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy of C21 in Subjects With COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of C21 in Subjects With COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04452435).
- Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults: primary endpoint results, effect estimate with confidence…
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety and Efficacy of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload – a Non-comparative Extension Study: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From…
- Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic…
- Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy of Hypothermia to Treat Neonatal Hypoxic-Ischemic Encephalopathy: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Hypothermia to Treat Neonatal Hypoxic-Ischemic Encephalopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00890409).
- Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01446042).
- Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02311153).
- Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM: Complete Statistical AnalysisIndependent statistical analysis of Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…